series-c-plus
Stage
1
Investors
About
X4 Pharmaceuticals develops therapeutics targeting the CXCR4 receptor for the treatment of rare immune disorders and hematologic diseases.
Explore X4 Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.